OncoDNA

OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases.

OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late stage cancer patients, but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA grew into a corporate group of companies with world-renown expertise. The Group offers a unique portfolio that combines NGS services, biomarker testing, data interpretation software, and clinical decision support tools. OncoDNA is headquartered in Belgium, and its entities – Biosequence and IntegraGen – are based in Spain, France and the United States. The Group employs over 100 employees across 9 countries, works with an international network of 35 distributors and collaborates with both European-based and US-based subcontracted accredited laboratories.

16/11/2023

🌟 A look back at ESMO - Presentation by Marcel Trautmann 🌟

🎥 Exclusive video : The OncoDEEP Kit - Transforming Molecular Profiling :

Dive into the world of molecular pathology with the video of Marcel Trautmann's presentation at ESMO

Discover how the OncoDEEP kit is revolutionising molecular profiling analysis, from tumour sample analysis to clinical interpretation. More than just a product presentation, this video reveals how our all-in-one solution simplifies and optimises the molecular analysis process. The OncoDEEP kit, a major advance in genomics, is also a cost-effective option, maximising the value of sequencing data for clinical interpretation.

🔗 https://youtu.be/pBGbg-gpGac?si=AiS48tsZUi3YIdKc

👉 Meet Marcel Trautmann at the DGP Congress: After his presentation at ESMO, he joins us in the 13th Herbsttreffen AG Molekularpathologie of the German Society for Pathology (DGP), set for November 17-18, 2023, at Kap Europa in Frankfurt/Main. His expertise in the OncoDEEP kit and his role in the precision oncology revolution are undeniable.

⚠️ Don't miss his presentation entitled "Analytical Validation & Implementation of the OncoDEEP Kit - A Comprehensive Genomic Profiling NGS Panel for Cancer Diagnostics" on Saturday 18 November, from 12.40pm to 1.10pm, and meet our team to find out how the OncoDEEP kit can transform your approach to cancer diagnosis and treatment.

21/09/2023

🔍 Question of the Week: What makes up the OncoDEEP® Kit panel?

In the evolving landscape of precision oncology, the OncoDEEP® Kit emerges as a leading solution with its comprehensive cancer gene panel. Crafted by oncology experts, it's tailored to encompass all clinically-relevant oncology targets. 🧬

At its core, the panel boasts:

✔ 638 genes
✔ Reporting genomic alterations (SNV, insertion, deletion, CNV)
✔ Complex genetic signatures including HRD, MSI, and TMB.

Swipe through our carousel to explore the specific genes and delve deeper into our panel's capabilities.

19/09/2023

🏅 OncoDNA Sports News

Congratulations to the OncoDNA team who took part in the 12th inter-company challenge in Gosselies, in aid of ELA (European Leukodystrophy Association) 🎉

The team was a true embodiment of team spirit and sportsmanship. They wore OncoDNA’s colors proudly and ran with heart and determination among the other groups. 💪

Let's give a big shout-out to Iuliia for stepping up at a moment's notice, along with Carole, Cédric, Alexandre, Nicolas, and François.

Well done, everyone! We are proud of you 🏆

15/09/2023

𝗢𝗻𝗰𝗼𝗗𝗡𝗔 𝗮𝘁 𝗘𝗦𝗠𝗢 𝟮𝟬𝟮𝟯!

📣 We're excited to announce our participation at the ESMO in Madrid from October 20th to 24th. Visit us at 𝗕𝗼𝗼𝘁𝗵 𝟱𝟴𝟯 𝗶𝗻 𝗛𝗮𝗹𝗹 𝟱 and meet the OncoDNA's team. We have prepared an interactive activity with prizes to be won.

🤝 Get to know our diverse team:

🧪 Scientific Support
💼 Business Development
🌐 Key Account Management
💡 Strategy & Innovation
🩺 Medical Leadership ... and many more!

Whether you're whether you want to find out about our new products, talk to our team or discuss new medical advances come and visit us on our stand.

👋 See you at the ESMO - European Society for Medical Oncology !

08/09/2023

🔍 "Finding Waldo is fun, but meeting Marc and Alexander at ECP might be even more rewarding!" 🔍

Just like searching for Waldo in a crowd, Marc and Alexander are ready to be "found" at the 35th European Congress of Pathology in Dublin. They're eager to discuss the latest innovations in oncology and share insights about our products with you.

📅 Want to "spot" them between September 9-13? Schedule a time ECP2023oncodna@oncodna.com/bookings/" rel="ugc" target="_blank">https://outlook.office365.com/owa/calendar/ECP2023oncodna@oncodna.com/bookings/ for a coffee and an enriching conversation.

05/09/2023

🔬 Welcome to our "Question of the Week" series! 🔬

This week, we're diving deep into the OncoDEEP Kit, a best-in-class biomarker testing lab-oriented solution for tumor tissues. 🧬💡

👉 Learn more about how OncoDEEP Kit can revolutionize your lab's capabilities by visiting https://lab.oncodna.com.

29/08/2023

🌟 Team Building Day at OncoDNA! 🌟

We had an amazing day filled with laughter, teamwork, and unforgettable memories. It's moments like these that remind us of the strength and unity of our team. Swipe to see some highlights from our day!

28/06/2023

📣 Today is THE day! We are thrilled to announce the launch of our new lab solutions dedicated portal! 🚀

After months of hard work and collaboration, we are proud to present a platform that will revolutionize the way scientific professionals’ access high-value materials and stay up to date with the latest advancements in the field of oncology, genetics, and precision medicine.

Our lab solutions dedicated portal will be a game-changer for researchers, clinicians, and lab professionals who will be able to access cutting-edge scientific information, including research papers, clinical cases, testimonials and much more 🤩. We are excited to empower you with the knowledge and resources you need to drive innovation, enhance patient care, and make a lasting impact 🧬🔬.

Explore our portal today and join the wave of scientific innovation! Let's shape the future of healthcare together.
👉Visit https://lab.oncodna.com to learn more.

OncoDNA

13/09/2022

We have enjoyed attending the annual congress, one of the biggest oncology congresses in the world.

We look forward to seeing many of you again next year at ESMO in Madrid, Spain, 20-24 October 2023 🙌.

12/07/2022

ALK. ROS1. FGFR. NTRK. BRAF. Do you know what these have in common?

Exactly! They are all biomarkers that can predict a patient’s sensitivity to targeted and hormone therapy.

In this video, we explain the role they play in treatment and how to detect them in patients.

https://www.youtube.com/watch?v=wFI4NqTdZjM

14/06/2022

Why is it important to test patients with metastatic castration-resistant prostate cancer (mCRPC) for androgen receptor splicing variants 7 (AR-V7)? 🧬

Detecting ARV7 can help predict low efficacy of secondary such as abiraterone or enzalutamide for mCRPC patients. In opposite to most cancer biomarkers, AR-V7 is not that easy to detect. This particular biomarker can only be detected at protein or RNA level.

At OncoDNA, we decided to use next-generation sequencing to identify RNA biomarkers in solid tumors. Our is a comprehensive biomarker test that uniquely combines DNA, RNA and protein analyses to maximize the chance of identifying effective treatment options for cancer patients in one single test. Get to know more http://ow.ly/zePx50HXBgX

Adres

1 Rue Louis Bréguet
Charleroi
6041

Telefoon

+3271183500

Website

https://www.oncodna.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer OncoDNA nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.